Glycine reuptake inhibitors for treating drug and alcohol dependence

Details for Australian Patent Application No. 2006205796 (hide)

Owner N.V. Organon

Inventors Soderpalm, Bo; Molander, Anna

Agent Spruson & Ferguson

Pub. Number AU-B-2006205796

PCT Pub. Number WO2006/075011

Priority 05100218.6 14.01.05 EP

Filing date 11 January 2006

Wipo publication date 20 July 2006

Acceptance publication date 2 September 2010

International Classifications

A61K 31/198 (2006.01)

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

A61P 25/36 (2006.01) Drugs for disorders of the nervous system

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/075011 Priority application(s): WO2006/075011

2 September 2010 Application Accepted

  Published as AU-B-2006205796

6 January 2011 Standard Patent Sealed

22 December 2011 Alteration of Name

  The name of the patentee has been altered to MSD Oss B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006205797-Pyrrolodihydroisoquinolines as antiproliferative agents

2006205762-Microporous crystalline material, zeolite ITQ-33, preparation method thereof and use of same